SOURCE: Global Matrechs, Inc.

April 11, 2007 10:14 ET

Global Matrechs Completes First Payment to Dow Corning

RIDGEFIELD, CT -- (MARKET WIRE) -- April 11, 2007 -- Global Matrechs, Inc. (OTCBB: GBMR) today announced that pursuant to its contract with Dow Corning for the manufacture of NuCap™, Global Matrechs has completed its initial payment of $125,000 to Dow Corning. These funds will be used by Dow Corning to upgrade manufacturing equipment which will provide efficiencies in the NuCap™ manufacturing process. Upon the completion of these improvements, Global Matrechs will be obligated to complete its payment in the amount of $140,000 for the capital improvements. Global Matrechs anticipates that the completion of these improvements will occur by the fourth quarter 2007.

About Global Matrechs

Global Matrechs (OTCBB: GBMR) ( operates a license technologies business. Through its licensed technologies, Global Matrechs seeks to convert the licenses it has acquired in emerging technologies in the nuclear energy, environmental and chemical industries into manufactured products primarily through the sub-licenses of those technologies to manufacturers.

About Dow Corning

Dow Corning was established in 1943 specifically to explore the potential of silicones. It was created as a joint venture between Corning Glass Works (now Corning, Incorporated) and The Dow Chemical Company. Today Dow Corning provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicon-based technology and innovation, offering more than 7,000 products and services, Dow Corning is equally owned by The Dow Chemical Company and Corning, Incorporated.

"Forward-Looking Statements"

Investors are cautioned that certain statements contained in this document, as well as other statements in periodic press releases and some oral statements of Global Matrechs, Inc. officials during presentations, are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act").

Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, or which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," "hopes," "seeks," or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by management, are also forward-looking statements as defined by the Act.

Some of the factors that could significantly impact these forward-looking statements in this press release include, but are not limited to: insufficient cash flow to continue to fund the development and marketing of the Company's products and technologies; the failure of the Company's products and technologies to become commercially marketable; the loss of key personnel; changes in financial markets and general economic conditions; and, disputes as to the Company's intellectual property rights, including the Company's rights to the technologies that it licenses from Eurotech, Ltd. Forward-looking statements are based upon current expectations and projections about future events and are subject to risks, uncertainties, and assumptions about Global Matrechs, its licenses, products, economic and market factors and the sectors in which Global Matrechs does business, among other things. These statements are not guarantees of future performance and Global Matrechs has no specific intention to update these statements. More detailed information about those factors is contained in Global Matrechs's filings with the Securities and Exchange Commission.

Contact Information

  • Contact:
    Global Matrechs, Inc.